4502 On Other Exchanges
Symbol
Exchange
4502 is not on other exchanges.

Executive Profile*

Deborah Dunsire M.D.

AgeTotal Calculated CompensationThis person is connected to 183 board members in 6 different organizations across 10 different industries.

See Board Relationships
54--

Background*

Dr. Deborah Dunsire, MD., has been Chief Executive Officer, President and Director of XTuit Pharmaceuticals, Inc. since March 2017. Dr. Dunsire served as the Chief Executive Officer and President of FORUM Pharmaceuticals Inc. (previously EnVivo Pharmaceuticals) since July 11, 2013. Dr. Dunsire served as the Chief Executive Officer and President at Millennium Pharmaceuticals, Inc., from July 2005 to May 09, 2013. She has more than 25 years of scientific, clinical, operational ...

Read Full Background

\

Corporate Headquarters*

12-10, Nihonbashi 2-chome
Osaka, -- 103-8668

Japan

Phone: 81 3 3278 2111
Fax: 81 3 3278 2880

Board Members Memberships*

Director
Director At Large
2006-Present
Independent Director
2013-Present
Director
2017-Present
Independent Director
2017-Present
Chief Executive Officer, President and Director

Education*

MD
University of the Witwatersrand
Bachelor's Degree
Wits Medical School

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TAKEDA PHARMACEUTICAL CO LTD, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.